Details for New Drug Application (NDA): 217821
✉ Email this page to a colleague
NDA 217821 describes BUPIVACAINE HYDROCHLORIDE, which is a drug marketed by Aspiro, Civica, Eugia Pharma, Hikma Pharms, Hospira, Meitheal, Somerset, Steriscience Speclts, B Braun Medical Inc, Baxter Hlthcare Corp, Huons, and Intl Medicated, and is included in thirty-four NDAs. It is available from nineteen suppliers. Additional details are available on the BUPIVACAINE HYDROCHLORIDE profile page.
The generic ingredient in BUPIVACAINE HYDROCHLORIDE is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
The generic ingredient in BUPIVACAINE HYDROCHLORIDE is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
Summary for 217821
| Tradename: | BUPIVACAINE HYDROCHLORIDE |
| Applicant: | Aspiro |
| Ingredient: | bupivacaine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 217821
| Physiological Effect | Local Anesthesia |
Suppliers and Packaging for NDA: 217821
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BUPIVACAINE HYDROCHLORIDE | bupivacaine hydrochloride | INJECTABLE;INJECTION | 217821 | ANDA | Camber Pharmaceuticals, Inc. | 31722-275 | 31722-275-31 | 10 VIAL, SINGLE-DOSE in 1 CARTON (31722-275-31) / 10 mL in 1 VIAL, SINGLE-DOSE |
| BUPIVACAINE HYDROCHLORIDE | bupivacaine hydrochloride | INJECTABLE;INJECTION | 217821 | ANDA | Camber Pharmaceuticals, Inc. | 31722-275 | 31722-275-32 | 25 VIAL, SINGLE-DOSE in 1 CARTON (31722-275-32) / 10 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.25% | ||||
| Approval Date: | Mar 27, 2024 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.5% | ||||
| Approval Date: | Mar 27, 2024 | TE: | AP | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.75% | ||||
| Approval Date: | Mar 27, 2024 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
